Description | TTQ-F-PEG-RGD,4,9-bis(5-bromothiophen-2-yl)-6,7-bis(4-(hexyloxy)phenyl)-[1,2,5]thiadiazolo[3,4-g]quinoxaline-polyethylene glycol-RGD has high NIR-II strength, good stability and affinity for activated platelets. It can be used to target glioma and thrombus, and distinguish fresh thrombus from old thrombus. It can also specifically target thrombosis in vivo and in vitro, which provides a potential tool for noninvasive diagnosis of early thrombosis. |
Purity | 90% |
Storage | -20°C protected from light and moisture |
Excitation Wavelength | 739 nm |
Emission Wavelength | 997 nm |
Shelf-life | 1 year |
Catalog: CDRXL24-110-L
Catalog: CDRXL24-111-L
Catalog: CDRXL24-124-L
Catalog: CDRXL24-125-L
Catalog: CDRXL24-126-L
Catalog: CDRXL24-127-L
Catalog: CDRXL24-128-L
Catalog: CDRXL24-129-L